These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 177371)

  • 1. Use of cryopreserved virus-infected target cells in a lymphocytotoxicity 51Cr release microassay for cell-mediated immunity to cytomegalovirus.
    Thong YH; Hensen SA; Vincent MM; Fuccillo DA; Stiles WA; Bellanti JA
    Infect Immun; 1976 Feb; 13(2):643-5. PubMed ID: 177371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific impairment of cell-mediated immunity in mothers of infants with congenital infection due to cytomegalovirus.
    Rola-Pleszczynski M; Frenkel LD; Fuccillo DA; Hensen SA; Vincent MM; Reynolds DW; Stagno S; Bellanti JA
    J Infect Dis; 1977 Mar; 135(3):386-91. PubMed ID: 191541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 51Chromium-release microassay technique for cell-mediated immunity to mumps virus: correlation with humoral and delayed-type skin hypersensitivity responses.
    Rola-Pleszczynski M; Vincent MM; Hensen SA; Walser J; Crawford M; Bellanti JA
    J Infect Dis; 1976 Dec; 134(6):546-51. PubMed ID: 1003011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte activation in subacute sclerosing panencephalitis virus and cytomegalovirus infections. In vitro stimulation in response to viral-infected cell lines.
    Thurman GB; Ahmed A; Strong DM; Knudsen RC; Grace WR; Sell KW
    J Exp Med; 1973 Oct; 138(4):839-46. PubMed ID: 4355279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of microassay technique in cell-mediated immunity to measles virus infection.
    Yamanaka T; Chiba S; Nakao T
    Tohoku J Exp Med; 1976 Nov; 120(3):225-9. PubMed ID: 996848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardization of the chromium-51 release, cell-mediated cytotoxicity assay: cryopreservation of mouse effector and target cells.
    Holden HT; Oldham RK; Ortaldo JR; Herberman RB
    J Natl Cancer Inst; 1977 Mar; 58(3):611-22. PubMed ID: 839557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune balance in the cytomegalovirus-infected host: in vitro studies of virus-lymphocyte interactions and the effects on specific lymphocyte function.
    Casali P; Rice GP; Oldstone MB
    Birth Defects Orig Artic Ser; 1984; 20(1):149-59. PubMed ID: 6329358
    [No Abstract]   [Full Text] [Related]  

  • 8. 51Cr release microassay for measuring cell-mediated immunity in chickens.
    Radwan AI; Buening GM; Loan RW
    Infect Immun; 1975 Mar; 11(3):436-40. PubMed ID: 1116876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
    Weinberg A; Wohl DA; Barrett RJ; van der Horst C
    J Infect Dis; 2001 Sep; 184(6):707-12. PubMed ID: 11517431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the status of cell-mediated immunity in cytomegalovirus-infected renal allograft recipients.
    Rytel MW; Aguilar-Torres FG; Balay J; Heim LR
    Cell Immunol; 1978 Apr; 37(1):31-40. PubMed ID: 207446
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased cytotoxicity against cytomegalovirus-infected target cells by bronchoalveolar lavage cells from bone marrow transplant recipients with cytomegalovirus pneumonia.
    Bowden RA; Dobbs S; Kopecky KJ; Crawford S; Meyers JD
    J Infect Dis; 1988 Oct; 158(4):773-9. PubMed ID: 2844915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune reaction to human cytomegalovirus].
    Ito M
    Nihon Rinsho; 1998 Jan; 56(1):62-8. PubMed ID: 9465666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-cell cultures from virus-sensitized donors can mediate virus-specific and HLA-restricted cell lysis.
    Sethi KK; Stroehmann I; Brandis H
    Nature; 1980 Aug; 286(5774):718-20. PubMed ID: 6251371
    [No Abstract]   [Full Text] [Related]  

  • 14. A 51 Cr microassay technique for cell-mediated immunity to viruses.
    Steele RW; Hensen SA; Vincent MM; Fuccillo DA; Bellanti JA
    J Immunol; 1973 Jun; 110(6):1502-10. PubMed ID: 4712922
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants.
    Lacey SF; Diamond DJ; Zaia JA
    Biol Blood Marrow Transplant; 2004 Jul; 10(7):433-47. PubMed ID: 15205665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural cytotoxic activity against cytomegalovirus-infected target cells following marrow transplantation.
    Bowden RA; Day LM; Amos DE; Meyers JD
    Transplantation; 1987 Oct; 44(4):504-8. PubMed ID: 2823422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus.
    Ho M
    Infect Immun; 1980 Mar; 27(3):767-76. PubMed ID: 6247279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired cellular immunity to cytomegalovirus in congenitally infected children and their mothers.
    Starr SE; Tolpin MD; Friedman HM; Paucker K; Plotkin SA
    J Infect Dis; 1979 Oct; 140(4):500-5. PubMed ID: 229172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cytomegalovirus-specific CD4+ cytotoxic T lymphocytes from seropositive or negative healthy subjects or stem cell transplant recipients.
    Tazume K; Hagihara M; Gansuvd B; Higuchi A; Ueda Y; Hirabayashi K; Hojo M; Tanabe A; Okamoto A; Kato S; Hotta T
    Exp Hematol; 2004 Jan; 32(1):95-103. PubMed ID: 14725906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies.
    Moller-Larsen A; Heron I; Haahr S
    Infect Immun; 1977 Apr; 16(1):43-7. PubMed ID: 194838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.